Your heartHealthy livingFor professionalsResearchHow you can helpAbout us

Dr Yow Keat Tham

Research directory


Dr Yow Keat Tham

Targeting novel lipids in an oral based treatment for the failing heart

Dr Yow Keat Tham, Baker Heart and Diabetes Institute

2021 Vanguard Grant

Years funded: 2022-2022

Cardiovascular disease remains the leading cause of death worldwide. New therapies are required to address this major unmet need. Lipids (molecules such as fats) are a major component of cell membranes including heart muscle cells. Recent studies have shown that lipids are altered in various pathologies, such as cardiovascular disease. Plasmalogens are a specific type of lipid that are enriched in the heart. Previous studies demonstrate that plasmalogen levels were reduced in a variety of disease settings such as atherosclerosis, and a dietary supplementation strategy conferred benefit against these disease types.

The major aims of Dr Yow Keat Tham's research project is to:

  • non-invasively increase plasmalogens levels in a preclinical model of heart failure via dietary supplementation, and
  • assess how increasing plasmalogen levels may benefit the failing heart.

Expected outcomes: Dietary supplementation will increase plasmalogen levels in the heart and confer benefit against heart failure.

Last updated28 March 2022